ChiCTR2200063167 版本V1.1 版本创建时间2023/04/06 16:26:54 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200063167 

最近更新日期:

Date of Last Refreshed on:

2022-09-01 18:34:56 

注册时间:

Date of Registration:

2022-09-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

创建新型颅脑创伤昏迷程度评价系统的多中心概念验证研究

Public title:

A multi-center proof-of-concept study to create a novel craniocerebral trauma coma degree assessment system

注册题目简写:

English Acronym:

研究课题的正式科学名称:

神经外科

Scientific title:

Neurosurgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

沙壮 

研究负责人:

江荣才 

Applicant:

Sha Zhuang 

Study leader:

Jiang Rongcai 

申请注册联系人电话:

Applicant telephone:

13852440736

研究负责人电话:

Study leader's
telephone:

13672116556

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

shazhuangxzykdx@163.com

研究负责人电子邮件:

Study leader's E-mail:

jiang116216@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市和平区鞍山道154号

研究负责人通讯地址:

天津市和平区鞍山道154号

Applicant address:

No. 154 Anshan Road, Heping District, Tianjin

Study leader's address:

No. 154 Anshan Road, Heping District, Tianjin

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津医科大学总医院

Applicant's institution:

Tianjin Medical University General Hospital

研究负责人所在单位:

天津医科大学总医院

Affiliation of the Leader:

Tianjin Medical University General Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

IRB2022-KY-335

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津医科大学总医院伦理委员会

Name of the ethic committee:

The Ethical Committee of Tianjin Medical University General Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-07-14 00:00:00

伦理委员会联系人:

金冬来

Contact Name of the ethic committee:

Donglai Jin

伦理委员会联系地址:

天津市和平区鞍山道154号

Contact Address of the ethic committee:

No. 154 Anshan Road, Heping District, Tianjin

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 022-60361044

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

天津医科大学总医院

Primary sponsor:

Tianjin Medical University General Hospital

研究实施负责(组长)单位地址:

天津市和平区鞍山道154号

Primary sponsor's address:

No. 154 Anshan Road, Heping District, Tianjin

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

Tianjin

City:

单位(医院):

天津医科大学总医院

具体地址:

和平区鞍山道154号

Institution
hospital:

Tianjin Medical University General Hospital

Address:

154 Anshan Road, Heping District

经费或物资来源:

天津医科大学总医院

Source(s) of funding:

Tianjin Medical University General Hospital

研究疾病:

颅脑创伤  

Target disease:

Traumatic brain injury

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

研究以智能情感识别技术分辨中重型TBI的轻重程度的可能性,初步开发新型TBI昏迷程度评价新系统。  

Objectives of Study:

To study the possibility of distinguishing the severity of moderate and severe TBI with intelligent emotion recognition technology, and initially develop a new system for evaluating the degree of coma in TBI.

药物成份或治疗方案详述:

非药物研究及治疗方案 

Description for medicine or protocol of treatment in detail:

Non-drug research and treatment options 

纳入标准:

(1)伤后24小时内入院的急性轻中重特重型(GCS3~15)TBI患者。
(2)年龄18~65岁。
(3)有明确临床症状体征。
(4)均只接受保守治疗。
(5)均有7天内的头CT影像检查结果

Inclusion criteria

(1) Patients with acute mild, moderate and severe (GCS3-15) TBI admitted to hospital within 24 hours after injury.
(2) Age 18 to 65 years old.
(3) There are clear clinical symptoms and signs.
(4) All received conservative treatment only.
(5) Head CT imaging results within 7 days

排除标准:

(1)躁动不安,无法完成至少1分钟视频采集。
(2)无自主呼吸以及心跳骤停者。
(3)因病情需要给予镇痛镇静影响患者意识者。
(4)入院后24小时内就病情加重,GCS下降到3~5分的濒死患者。
(5)预计无法生存超过3个月者。
(6)合并其他大脏器严重损伤(包括颈髓损伤),导致生命体征不稳定。
(7)手术后头面部变形、为止血包裹不能解开面部覆盖物,致智能技术无法观测。
(8)伤后症状体征严重但颅CT表现轻微患者(中重型弥漫性轴索损伤患者)。

Exclusion criteria:

(1) Restless and unable to complete video capture for at least 1 minute.
(2) Those without spontaneous breathing and cardiac arrest.
(3) Those who need to give analgesia and sedation to affect the patient's consciousness due to the condition.
(4) Dying patients whose condition worsened within 24 hours after admission and whose GCS dropped to 3-5 points.
(5) Those who are not expected to survive for more than 3 months.
(6) Combined with severe damage to other large organs (including cervical spinal cord injury), resulting in unstable vital signs.
(7) After the operation, the head and face are deformed, and the hemostatic wrap cannot untie the facial covering, which makes the intelligent technology unable to observe.
(8) Patients with severe symptoms and signs after injury but mild cranial CT manifestations (patients with moderate to severe diffuse axonal injury).

研究实施时间:

Study execute time:

From 2022-08-01 00:00:00 To 2025-08-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-01 00:00:00 To 2024-09-01 00:00:00

干预措施:

Interventions:

组别:

颅脑创伤组

样本量:

60

Group:

Traumatic brain injury group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

天津 

市(区县):

 

Country:

China

Province:

Tianjin

City:

单位(医院):

天津医科大学总医院 

单位级别:

三级甲等 

Institution
hospital:

Tianjin Medical University General Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

唐山 

Country:

China

Province:

Hebei

City:

Tangshan

单位(医院):

唐山市工人医院 

单位级别:

三级甲等 

Institution
hospital:

Tangshan Workers Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

临沂 

Country:

China

Province:

Shandong

City:

Linyi

单位(医院):

临沂市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Linyi People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

嘉兴 

Country:

China

Province:

Zhejiang

City:

Jiaxing

单位(医院):

海宁市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Haining People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

鄂尔多斯 

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

Ordos

单位(医院):

内蒙古鄂尔多斯中心医院 

单位级别:

三甲 

Institution
hospital:

Ordos Central Hospital, Inner Mongolia

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

面部表情视频

指标类型:

主要指标

Outcome:

facial expression video

Type:

Primary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

格拉斯哥昏迷评分

指标类型:

主要指标

Outcome:

Glasgow Coma Scale

Type:

Primary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

血压

指标类型:

次要指标

Outcome:

Blood pressure

Type:

Secondary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

Heart rate

Type:

Secondary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

呼吸频率

指标类型:

次要指标

Outcome:

Respiratory rate

Type:

Secondary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

扩展版格拉斯哥结局量表评分

指标类型:

次要指标

Outcome:

Glasgow Outcome Scale-Extended Score

Type:

Secondary indicator

测量时间点:

入院1个月、3个月和6个月后

测量方法:

Measure time point of outcome:

1 month, 3 months and 6 months after admission

Measure method:

指标中文名:

日常生活能力量表评分

指标类型:

次要指标

Outcome:

Activity of Daily Living Scale Score

Type:

Secondary indicator

测量时间点:

入院1个月、3个月和6个月后

测量方法:

Measure time point of outcome:

1 month, 3 months and 6 months after admission

Measure method:

指标中文名:

改良Rankin量表评分

指标类型:

主要指标

Outcome:

Modified Rankin Scale Score

Type:

Primary indicator

测量时间点:

入院1个月、3个月和6个月后

测量方法:

Measure time point of outcome:

1 month, 3 months and 6 months after admission

Measure method:

指标中文名:

脑电图

指标类型:

次要指标

Outcome:

Electroencephalogram

Type:

Secondary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

脑电双频指数

指标类型:

次要指标

Outcome:

Bispectral index

Type:

Secondary indicator

测量时间点:

入院24h内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

指标中文名:

心率变异性

指标类型:

次要指标

Outcome:

Heart rate variability

Type:

Secondary indicator

测量时间点:

入院24小时内

测量方法:

Measure time point of outcome:

Within 24 hours of admission

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

颅脑外伤急诊入院患者

Randomization Procedure (please state who generates the random number sequence and by what method):

Emergency admission of traumatic brain injury patients

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

-

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

-

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据收集病例记录表(Case Record Form, CRF)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data Collection Case Record Form (CRF)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-09-01 18:34:47